Connect with us

Opinion

Pfizer COVID-19 vaccine could be available for children under 5 as soon as next month: report

Published

on

Pfizer and BioNTech plan to submit a request for emergency use authorization for his or her COVID-19 vaccine in youngsters six months to five years previous as quickly as Tuesday, which may set the vaccine as much as be permitted for younger youngsters within the coming weeks, the Washington Publish reviews. 

The businesses started a medical trial final yr to look at the results of two doses of 3-microgram pictures in youngsters youthful than 5. 

Dr. Manjul Shukla transfers Pfizer COVID-19 vaccine right into a syringe, Thursday, Dec. 2, 2021, at a cell vaccination clinic in Worcester, Mass.
((AP Picture/Steven Senne))

The vaccine is already permitted for emergency use in youngsters between the ages of 5 and 11, who obtain 10 microgram doses. Kids older than 12 and adults obtain 30 microgram doses. 

‘STEALTH’ OMICRON VARIANT BA.2 CIRCULATING IN ALMOST HALF OF US, BUT CDC EXERCISES CAUTION: REPORT

Two 3-microgram doses had been discovered to be efficient in youngsters between six months and a pair of years previous, however youngsters between the ages of two and 5 didn’t have the identical immune response because the bigger two-dose sequence in older youngsters. 

21/12/25: A tray with vials containing Pfizer/BioNTech COVID-19 booster vaccine seen at a vaccination center.

21/12/25: A tray with vials containing Pfizer/BioNTech COVID-19 booster vaccine seen at a vaccination middle.
( Dinendra Haria/SOPA Photos/LightRocket through Getty Photos)

That discovering prompted Pfizer to check the administration of a 3rd 3-microgram dose two months after the final dose. 

The FDA urged Pfizer and BioNTech to go forward and submit the two-dose information so the approval course of may start, in keeping with the Washington Publish. 

Leah Lefkove, 9, covers her face as her dad Dr. Ben Lefkove gives her the first COVID-19 vaccine at the Viral Solutions vaccination and testing site in Decatur, Georgia.

Leah Lefkove, 9, covers her face as her dad Dr. Ben Lefkove provides her the primary COVID-19 vaccine on the Viral Options vaccination and testing website in Decatur, Georgia.
(AP Picture/Ben Grey)

Pfizer’s vaccine was approved for kids between the ages of 5 and 11 in late October. 

About three months later, solely 8.7 million youngsters between the ages of 5 and 11 have obtained no less than one dose and 6.2 million are totally vaccinated. 

CLICK HERE TO GET THE FOX NEWS

There have been 11.4 million COVID-19 circumstances in youngsters because the pandemic started, making up about 18.6% of all circumstances, however youngsters solely signify 1.6%-4.4% of all COVID-19 hospitalizations and 0.00%-0.25% of all COVID-19 deaths, in keeping with the American Academy of Pediatrics. 

Supply: Fox Information